Daniela Berg mainly investigates Parkinson's disease, Pathology, Disease, Substantia nigra and Internal medicine. Daniela Berg studies Alpha-synuclein which is a part of Parkinson's disease. Her research integrates issues of Echogenicity, Neurology, Central nervous system disease and Transcranial Doppler in her study of Pathology.
Her Disease research is multidisciplinary, incorporating elements of Psychiatry, Neuroscience and Physical therapy. Her Substantia nigra study also includes fields such as
Her main research concerns Parkinson's disease, Disease, Internal medicine, Pathology and Substantia nigra. Her research in Parkinson's disease intersects with topics in Physical medicine and rehabilitation, Dementia, Physical therapy and Neurology, Neuroscience. The various areas that she examines in her Disease study include Biomarker, Psychiatry, Depression and Cohort.
Her studies in Internal medicine integrate themes in fields like Gastroenterology, Endocrinology, Oncology and Cardiology. Her Pathology study frequently intersects with other fields, such as Central nervous system disease. Her biological study spans a wide range of topics, including Echogenicity, Transcranial Doppler and Degenerative disease.
Daniela Berg mostly deals with Parkinson's disease, Disease, Internal medicine, Physical medicine and rehabilitation and Cognition. Her Parkinson's disease study combines topics in areas such as Audiology, Cohort, Dementia, Prospective cohort study and Confounding. Her Disease study combines topics from a wide range of disciplines, such as Neurology, Neuroscience and microRNA.
Her Internal medicine research incorporates elements of Gastroenterology, Endocrinology and Oncology. The study incorporates disciplines such as Substantia nigra, Echogenicity and Parkinsonism in addition to Gastroenterology. Her Physical medicine and rehabilitation study integrates concerns from other disciplines, such as Levodopa and Treadmill.
Her primary areas of investigation include Parkinson's disease, Disease, Internal medicine, Physical medicine and rehabilitation and Prospective cohort study. Her studies deal with areas such as Pediatrics, Parkinsonism and Confounding as well as Parkinson's disease. Her Disease research is multidisciplinary, incorporating perspectives in Multiple sclerosis, microRNA and Depression.
Many of her studies on Internal medicine apply to Oncology as well. Daniela Berg interconnects Increased risk and Falling in the investigation of issues within Physical medicine and rehabilitation. Her Prospective cohort study research integrates issues from Gastroenterology and Prodromal phase.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma;Daniela Berg;Matthew Stern;Werner Poewe.
Movement Disorders (2015)
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Javier Simón-Sánchez;Claudia Schulte;Jose M Bras;Jose M Bras;Manu Sharma.
Nature Genetics (2009)
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
Ellen Sidransky;Michael A. Nalls;Jan O. Aasly;Judith Aharon-Peretz.
The New England Journal of Medicine (2009)
The Parkinson Progression Marker Initiative (PPMI)
Kenneth Marek;Danna Jennings;Shirley Lasch;Andrew Siderowf.
Progress in Neurobiology (2011)
MDS research criteria for prodromal Parkinson's disease
Daniela Berg;Ronald B. Postuma;Charles H. Adler;Bastiaan R. Bloem.
Movement Disorders (2015)
Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease
Karsten M. Strauss;L. Miguel Martins;Helene Plun-Favreau;Frank P. Marx.
Human Molecular Genetics (2005)
Loss-of-Function of Human PINK1 Results in Mitochondrial Pathology and Can Be Rescued by Parkin
Nicole Exner;Bettina Treske;Dominik Paquet;Kira Holmström.
The Journal of Neuroscience (2007)
Comprehensive Research Synopsis and Systematic Meta- Analyses in Parkinson's Disease Genetics: The PDGene Database
Christina M. Lill;Johannes T. Roehr;Johannes T. Roehr;Matthew B. McQueen;Fotini K. Kavvoura;Fotini K. Kavvoura;Fotini K. Kavvoura.
PLOS Genetics (2012)
Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury.
Daniela Berg;Wolfgang Roggendorf;Ute Schröder;Rüdiger Klein.
JAMA Neurology (2002)
Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome.
Alexander Zimprich;Monika Grabowski;Friedrich Asmus;Markus Naumann.
Nature Genetics (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: